RADICAVA (Mitsubishi Tanabe Pharma America, Inc.)
Welcome to the PulseAid listing for the RADICAVA drug offered from Mitsubishi Tanabe Pharma America, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mitsubishi Tanabe Pharma America, Inc. |
| NON-PROPRIETARY NAME: | edaravone |
| SUBSTANCE NAME: | EDARAVONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-05-05 |
| END MARKETING DATE: | 0000-00-00 |
RADICAVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | RADICAVA from Mitsubishi Tanabe Pharma America, Inc. |
| LABELER NAME: | Mitsubishi Tanabe Pharma America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/100mL) |
| START MARKETING DATE: | 2017-05-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70510-2171_52edc622-43b5-4f5e-9261-75a826c3e88d |
| PRODUCT NDC: | 70510-2171 |
| APPLICATION NUMBER: | NDA209176 |
Other EDARAVONE Pharmaceutical Manufacturers / Labelers:
